麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Rural Health Payout
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Cosmetic Surgery
  • Gavin Newsom
  • RFK Jr.
  • Medicaid Work Requirements

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 3 2019

Full Issue

19 Cities Hope To Continue Lawsuits Against Purdue Pharma Family Despite Company's Efforts To Get National Settlement

Purdue, and members of the family that owns it, are pursuing a settlement to end more than 2,600 federal lawsuits and hundreds more in state courts.

Local government lawsuits against the family that owns Purdue Pharma should be allowed to proceed even as the company attempts to reach a nationwide settlement in bankruptcy court over the toll of the opioids crisis, according to a court filing on Wednesday. The filing by 19 cities and towns in Connecticut, Massachusetts, New Jersey and Virginia comes amid acrimonious settlement negotiations with the maker of the painkiller OxyContin that is now playing out in a bankruptcy court in White Plains, New York. (Mulvihill, 10/2)

An Oklahoma judge made a $107 million miscalculation when he ordered consumer products giant Johnson & Johnson to pay $572 million to help clean up the state鈥檚 opioid crisis, attorneys for the company argue in a court filing. The company also is asking for a reduction in the judgment based on pre-trial settlements totaling $355 million that the state reached with Oxycontin-maker Purdue Pharma and Israeli-owned Teva Pharmaceutical Industries Ltd. (Murphy, 10/2)

Prestigious universities around the world have accepted at least $60 million over the past five years from the family that owns the maker of OxyContin, even as the company became embroiled in lawsuits related to the opioid epidemic, financial records show. Some of the donations arrived before recent lawsuits blaming Purdue Pharma for its role in the opioid crisis. But at least nine schools accepted gifts in 2018 or later, when states and counties across the country began efforts to hold members of the family accountable for Purdue鈥檚 actions. The largest gifts in that span went to Imperial College London, the University of Sussex and Yale University. (Binkley and McDermott, 10/3)

As opioid addiction increasingly pushes users into emergency rooms with the advent of fentanyl into Baltimore鈥檚 drug markets, city officials are looking to address a gap created in part when people are released from the hospital after an overdose without any connection to follow-up treatment. The state has awarded the Behavioral Health System Baltimore $849,000 for fiscal year 2020 to address the problem, which the organization says stems from a lack of staff on the city鈥檚 Mobile Crisis Team. (Davis, 10/2)

A Virginia doctor who prescribed more than 500,000 doses of opioids in two years was sentenced to 40 years in prison on Wednesday for leading what prosecutors called an interstate drug distribution ring. The overprescription of painkillers is one of the roots of the nation鈥檚 opioid crisis, and patients of Dr. Joel Smithers traveled hundreds of miles from neighboring states to pick up oxymorphone, oxycodone, hydromorphone and fentanyl, according to law enforcement officials. They said he prescribed controlled substances to every patient in the Martinsville, Va., practice he opened in August 2015. (Hassan, 10/2)

The sentence is lighter than it could have been. Smithers was facing up to life in prison and a fine of more than $200 million, according to officials at the U.S. Justice Department. Smithers was convicted by a jury in May on more than 800 federal drug charges 鈥 including one count of possessing with the intent to distribute controlled substances and one count of maintaining a place for the purpose of unlawfully distributing controlled substances. (Booker, 10/2)

The league would 鈥渁bsolutely鈥 like to add opioid testing for next season, said Dan Halem, the league鈥檚 deputy commissioner. Tony Clark, the executive director of the players鈥 association, said the union plans to work with the league to assess 鈥渁ll of our drug protocols relating to education, treatment and prevention.鈥 The parties have discussed whether to loosen baseball鈥檚 restrictions on marijuana 鈥 not specifically as a trade-off for opioid testing, but as part of the annual review of the sport鈥檚 drug policy, according to three people familiar with the talks but not authorized to comment publicly on them. (Shaikin, 10/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
  • Tuesday, April 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优